• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在补充血清和无血清培养基中,重组人白细胞介素3(IL-3)、IL-6、粒细胞巨噬细胞集落刺激因子(GM-CSF)和干细胞因子(SCF)对人脐血祖细胞生长的调节作用。

Modulation of human cord blood progenitor cell growth by recombinant human interleukin 3 (IL-3), IL-6, granulocyte-macrophage colony stimulating factor (GM-CSF) and stem cell factor (SCF) in serum-supplemented and serum-free medium.

作者信息

De Bruyn C, Delforge A, Bron D, Ley P, de Hemptinne D, Stryckmans P

机构信息

Service de Médecine Interne et Laboratoire d'Investigation Clinique Henri Tagnon, Institut J. Bordet, Brussels, Belgium.

出版信息

Stem Cells. 1994 Nov;12(6):616-25. doi: 10.1002/stem.5530120609.

DOI:10.1002/stem.5530120609
PMID:7533580
Abstract

UNLABELLED

We evaluated the growth of cord blood myeloid progenitors or colony forming units granulocyte-macrophage (CFU-GM) and their response to various recombinant growth factors or colony stimulating factors (CSFs): interleukin 3 (IL-3), IL-6, granulocyte-macrophage CSF (GM-CSF) and stem cell factor (SCF). Using classical stimulant (human placenta conditioned medium or HPCM), we observed a significantly higher day-14/day-7 CFU-GM ratio in CB than in bone marrow (BM). The association of IL-3, IL-6, GM-CSF and SCF induced significantly more CB day-14 CFU-GM than HPCM. This effect is significantly greater in CB than in bone marrow. Since fetal calf serum (FCS) is known to contain inhibitors, we have compared the ability of CSFs to induce CFU-GM formation in FCS-supplemented and FCS-free culture. In CB, using HPCM, we obtained significantly more CFU-GM in FCS-free medium than in FCS-supplemented medium. This difference was corrected by the addition of anti-transforming growth factor-beta (TGF-beta) neutralizing antibody. However, with the association of the four CSFs, no significant difference between FCS and FCS-free culture was observed.

IN CONCLUSION

a) day-14/day-7 CFU-GM ratio was higher in CB than in BM indicating that CB CFU-GM are more primitive than BM CFU-GM; b) FCS can be successfully replaced by serum-free medium; c) FCS contains inhibitors of day-14 CFU-GM and among them TGF-beta; and d) the association IL-3, SCF, GM-CSF and IL-6 seems able to totally overcome the inhibitory effect of FCS.

摘要

未标记

我们评估了脐血髓系祖细胞或粒细胞-巨噬细胞集落形成单位(CFU-GM)的生长情况以及它们对各种重组生长因子或集落刺激因子(CSF)的反应:白细胞介素3(IL-3)、IL-6、粒细胞-巨噬细胞集落刺激因子(GM-CSF)和干细胞因子(SCF)。使用经典刺激物(人胎盘条件培养基或HPCM),我们观察到脐血中第14天/第7天的CFU-GM比值显著高于骨髓(BM)。IL-3、IL-6、GM-CSF和SCF联合使用诱导的脐血第14天CFU-GM比HPCM显著更多。这种效应在脐血中比在骨髓中显著更大。由于已知胎牛血清(FCS)含有抑制剂,我们比较了CSF在补充FCS和无FCS培养中诱导CFU-GM形成的能力。在脐血中,使用HPCM,我们在无FCS培养基中获得的CFU-GM比在补充FCS的培养基中显著更多。通过添加抗转化生长因子-β(TGF-β)中和抗体可纠正这种差异。然而,对于四种CSF联合使用,在FCS和无FCS培养之间未观察到显著差异。

结论

a)脐血中第14天/第7天的CFU-GM比值高于骨髓,表明脐血CFU-GM比骨髓CFU-GM更原始;b)FCS可以成功地被无血清培养基替代;c)FCS含有第14天CFU-GM的抑制剂,其中包括TGF-β;d)IL-3、SCF、GM-CSF和IL-6联合使用似乎能够完全克服FCS的抑制作用。

相似文献

1
Modulation of human cord blood progenitor cell growth by recombinant human interleukin 3 (IL-3), IL-6, granulocyte-macrophage colony stimulating factor (GM-CSF) and stem cell factor (SCF) in serum-supplemented and serum-free medium.在补充血清和无血清培养基中,重组人白细胞介素3(IL-3)、IL-6、粒细胞巨噬细胞集落刺激因子(GM-CSF)和干细胞因子(SCF)对人脐血祖细胞生长的调节作用。
Stem Cells. 1994 Nov;12(6):616-25. doi: 10.1002/stem.5530120609.
2
Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.干细胞因子(c-kit配体)、粒细胞-巨噬细胞集落刺激因子及白细胞介素3对人长期骨髓培养中造血祖细胞的影响
Stem Cells. 1993 Sep;11(5):435-44. doi: 10.1002/stem.5530110511.
3
Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.脐带血血浆可增强细胞因子依赖的CD34+脐血髓系祖细胞早期亚群的体外扩增,但更有利于祖细胞较成熟亚群的扩增。
Blood Cells. 1994;20(2-3):436-54.
4
Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.白细胞介素-11刺激人造血CD34+和CD34+CD33-DR-细胞的增殖,并与干细胞因子、白细胞介素-3和粒细胞-巨噬细胞集落刺激因子协同作用。
Exp Hematol. 1993 Dec;21(13):1668-72.
5
Expansion in bioreactors of human progenitor populations from cord blood and mobilized peripheral blood.脐血和动员外周血中人类祖细胞群体在生物反应器中的扩增。
Blood Cells. 1994;20(2-3):482-90; discussion 491.
6
Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.干细胞因子(c-kit配体)增强人CD34+和CD34+CD33-DR-细胞依赖白细胞介素-9的增殖。
Exp Hematol. 1994 Aug;22(9):919-23.
7
Cord blood plasma-mediated ex vivo expansion of hematopoietic progenitor cells.脐血血浆介导的造血祖细胞体外扩增
Bone Marrow Transplant. 1994 Sep;14(3):347-53.
8
Effect of recombinant stem cell factor on clonogenic maturation and cycle status of human fetal hematopoietic progenitors.重组干细胞因子对人胎儿造血祖细胞克隆形成成熟及细胞周期状态的影响。
Pediatr Res. 1994 Mar;35(3):303-6. doi: 10.1203/00006450-199403000-00004.
9
Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.促红细胞生成素和粒细胞-巨噬细胞集落刺激因子在无血清条件下对原始骨髓细胞巨核细胞生成的差异作用。
Stem Cells. 1997;15(4):286-90. doi: 10.1002/stem.150286.
10
Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis.干细胞因子增强肿瘤坏死因子-粒细胞巨噬细胞集落刺激因子介导的树突状细胞造血作用。
Stem Cells. 1995 Mar;13(2):186-97. doi: 10.1002/stem.5530130210.

引用本文的文献

1
Comparison of TGFbR2 down-regulation in expanded HSCs on MBA/DBM scaffolds coated by UCB stromal cells.脐血基质细胞包被的MBA/DBM支架上扩增的肝星状细胞中TGFbR2下调情况的比较。
In Vitro Cell Dev Biol Anim. 2015 May;51(5):495-506. doi: 10.1007/s11626-014-9854-y. Epub 2014 Dec 25.
2
Cord blood from collection to expansion: feasibility in a regional blood bank.
Indian J Pediatr. 2003 Apr;70(4):327-36. doi: 10.1007/BF02723589.